9 th - 11 th of March nd Jordan JFDA International Congress

Transcription

1 2 nd announcement 9 th - 11 th of March 2018 Fairmont Amman Hotel (Amman-Jordan) Preconference workshop on March 9 th, nd Jordan JFDA International Congress المو تمر الدولي الثاني للمو سسة العامة للغذاء والدواء الصناعات الدواي ية والدراسات السريرية نحو النمو والابتكار

2 Dear Colleagues, On behalf of the executive committee, it gives us pleasure to announce the 2nd International Congress of Jordan Food and Drug Administration, Pharma industry and clinical trials Growth & Innovation Which is going to be held on 9-11 March / 2018 at Fairmont Amman Hotel - Amman Jordan (Pre workshop on 9 th March). We cordially invite health care policy makers, academic institutions, health related associations, regulatory regional and international bodies, Local, regional and multinational pharmaceutical,cros, researchers and other health care professionals to participate in this Congress sharing their knowledge and research in the arena of clinical studies and advanced technology in pharmaceutical field. National and international speakers and leading experts from the field will provide comprehensive, up-to-date, research-based presentations and plenary sessions. it will also be a great platform networking in order to interact and enrich the discussions and subjects that are important for the future policies and regulations. 2nd International Congress anticipates more than 300 participants around the region and will be an excellent opportunity for the delegates to interact with the experts in the field. Looking forward to welcome you in March, 2018 in the beautiful city of Amman. Yours sincerely, Dr. Hayel Obeidat President of the Congress JFDA Director General

3 Pharma industry and Clinical Trials growth & innovation Main topics of the conference will be International Clinical Trials & New Era in Medicine which will focus on Innovations in Clinical trials. Trends in the Globalization of Clinical Trials, Economic Potentials. The importance of including MENA region and Jordan in Global Clinical trials. Conducting of clinical trials...legal, regulatory,development and design frame. Challenges facing Globalization of Clinical Trials. Globalization of clinical trials in immune therapy and Precision oncology. Role clinical research in PE analysis and setting priorities in healthcare. Explaining the Time, Risk, & Cost. Clinical Trials in Stem Cell Therapy. Role of CROs. Globalization of Vaccinations trials. Applying pharmaeconomics models in drawing clinical guidelines and setting priorities.

4 Drive growth & innovation in pharmaceuticals manufacturing: To remain competitive, manufacturers will need to focus on continual innovation & improvement. The Landscape for Pharmaceutical Innovation: Improve health outcomes and contain rising medical costs is driving the need for new and innovative products. Development of hybrid drugs and future. Biopharmaceutical development (Biologics and biosimilars): advances, concepts of development (including regulatory aspects). Nano-pharma futures in pharmaceutical industry. Pharma companies key challenges to further growth in emerging markets Capturing future opportunities, and focus on strategic priorities. Quality control in generic manufacturing. Role of national pharmacovigilance programs in modern medicine (stem cell therapy, biologics&biosimilars, immunetherapy, nanomedicine). Preconference workshop Introduction to Clinical Trials Preconference workshop Immuno-therapy and Precision Oncology In Collaboration with

5 on the 1 Memories st Jordan JFDA International Congress For more information please contact JORDAN VALLEY Conferences & Exhibitions Services Phone: (962) (6) ( ). Fax: (962) (6) ( ). Mobile: (962) ( ) info@jordan-valley.com. Web-site: Weather Average temperature in March 15 o -20 o C General Information JORDAN O R Currency One Jordanian Dinar is equivalent to 1.4 US Dollar Where to go in Jordan Amman City Tour (Roman Theater, Citadel, Shopping), Jerash, Ajloun, Madaba, Mount Nebo, Dead Sea, Baptism Site, Desert Castles, Petra the 2nd of the seven world wonders, Wadi Rum, Aqaba.

6 Registration Fees Certification The Registration fees include: Access to the opening ceremony, the scientific sessions, lunches, coffee breaks, and congress bag which includes a certificate of attendance, and abstracts book with final program. for Registration jordan valley Mobile: (962) ( ) info@jordan-valley.com Registration Fees 250$ Who will Attend Representatives from: - Health authorities, regulatory agencies, ministries of health - Regional managers & regulatory affairs managers from local and multi-national pharmaceutical companies - Regulatory affairs - Academic institutions - Health related associations - CROs, researchers Single Double (145JD) (155JD) - Above rates per night per room and Inclusive of 10% service charge & 16% sales tax. - Above rates include Buffet Breakfast.

7 The Higher Executive Committee H.E. Dr. Hayel Obeidat Director General, Jordan Food and Drug Administration, Amman, Jordan H.E. Dr. Yousef Al-Qsous Chairman of The Jordanian Senate Committee of Health H.E Dr. Dr. Abdullah Al-Bashir General Manager of Jordan Hospital Dr. Wesal Al- Haqaish Drug director-jfda H.E Eng. Mohammed Bataineh AmCham Chairman Dr. Munir Abu Hilaleh Regional Director; Middle East and North Africa, Global Academy for Health Sciences, Ohio, USA Dr. Rakan Rsheidat Managing director Omnitrade Pharma Dr. Lubna Al- Qusous Lab Director-JFDA Dr.Hanan Al-Sboul Secretary General The Jordanian Association of Pharmaceutical Manufacturers (JAPM) Dr. Thamer Obeidat Secretary General Drugstores Owners Association Dr. Firas Zuaiter PhRMA LAWG Chairman President of the Conference Dr. Hayel Obeidat Director General, JFDA, Amman, Jordan

8 International Faculty Prof. David Kerr Professor of Oncology and Hematology, ex-president of ESMO, university of Oxford, Ex-Health Advisor for the Prime Minister, UK, Chair of National Cancer Services Collaboratives, Founder Commissioner for NHS Health Improvement. Prof. Alex Adjei Director of Early cancer therapeutics program at Mayo Clinic 3 sites. Director of Global Oncology. Professor of Oncology, Mayo clinic, Rochester, USA Prof. Rachel Kerr Head of Phase III clinical trials Unit, Professor of Oncology, University of Oxford, Oxford, UK Prof. Aung Naing, Director of Drug development at MD Anderson, Consultant Oncologist, Houston, Texas, USA Prof. Christian Rolfo Head of early clinical trials unit Consultant Oncologist. Antwerp University, Belgium Prof. Abdul Rahman Jazieh, Chairman of the International Affairs Committee, American Society of Clinical Oncology (ASCO), Chairman, Department of Oncology, King Saud bin Abdulaziz University for health sciences, Riyadh, KSA. Prof. Lakshminarayan Ranganath Clinical Director, the Robert Gregory National Alkaptonuria Centre, Medical Advisor to the AKU Society, University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK Dr. Paul Cornes Direcotor of the UK outcomes group, Bristol, UK Prof. Matthias Schmid Head of Department of Infection & Tropical Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS FT, Newcastle upon Tyne, UK Dr. Munir Abu-Helalah Associate professor of Epidemiology& Preventive medicine, Consultant Chronic Diseases control and prevention, Regional Director; Middle East, North Africa & Central Asia, Global Academy for Health Sciences, Ohio, USA Local Directors Dr. Wesal Haqaish Drug Director, Jordan Food and Drug Administration, Amman, Jordan Prof. Abdullah Awidi Professor of Hematology and Oncology, CEO of stem cell therapy center, the University of Jordan, Amman, Jordan Dr. Wael Hayajneh Dean, Faculty of Medicine, Jordan University of Science and Technology Irbid, Jordan

9 Local Directors Dr. Wesal Haqaish Drug Director, Jordan Food and Drug Administration, Amman, Jordan Prof. Abdullah Awidi Professor of Hematology and Oncology, CEO of stem cell therapy center, the University of Jordan, Amman, Jordan Dr. Wael Hayajneh Dean, Faculty of Medicine, Jordan University of Science and Technology Irbid, Jordan